Cargando…
Use of In Vitro Dynamic Colon Model (DCM) to Inform a Physiologically Based Biopharmaceutic Model (PBBM) to Predict the In Vivo Performance of a Modified-Release Formulation of Theophylline
A physiologically based biopharmaceutic model (PBBM) of a modified-release formulation of theophylline (Uniphyllin Continus(®) 200 mg tablet) was developed and implemented to predict the pharmacokinetic (PK) data of healthy male volunteers by integrating dissolution profiles measured in a biorelevan...
Autores principales: | Stamatopoulos, Konstantinos, O’Farrell, Connor, Simmons, Mark J. H., Batchelor, Hannah K., Mistry, Nena |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10058579/ https://www.ncbi.nlm.nih.gov/pubmed/36986743 http://dx.doi.org/10.3390/pharmaceutics15030882 |
Ejemplares similares
-
Integrating In Vitro Biopharmaceutics into Physiologically Based Biopharmaceutic Model (PBBM) to Predict Food Effect of BCS IV Zwitterionic Drug (GSK3640254)
por: Stamatopoulos, Konstantinos, et al.
Publicado: (2023) -
Dynamic Colon Model (DCM): A Cine-MRI Informed Biorelevant In Vitro Model of the Human Proximal Large Intestine Characterized by Positron Imaging Techniques
por: Stamatopoulos, Konstantinos, et al.
Publicado: (2020) -
The Effect of Biorelevant Hydrodynamic Conditions on Drug Dissolution from Extended-Release Tablets in the Dynamic Colon Model
por: O’Farrell, Connor, et al.
Publicado: (2022) -
A Mechanistic Physiologically-Based Biopharmaceutics Modeling (PBBM) Approach to Assess the In Vivo Performance of an Orally Administered Drug Product: From IVIVC to IVIVP
por: Bermejo, Marival, et al.
Publicado: (2020) -
Luminal Fluid Motion Inside an In Vitro Dissolution Model of the Human Ascending Colon Assessed Using Magnetic Resonance Imaging
por: O’Farrell, Connor, et al.
Publicado: (2021)